Ectosomes: A new mechanism for non-exosomal secretion of Tau protein

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Dujardin, Simon ^a,b   Bégard, Séverine ^a,b   Caillierez, Raphaëlle ^a,b   Lachaud, Cédrick ^a,b   Delattre, Lucie ^a,b   Carrier, Sébastien ^a,b   Loyens, Anne ^a,b   Galas, Marie Christine ^a,b,c   Bousset, Luc ^d   Melki, Ronald ^d   Aurégan, Gwennaëlle ^e,f   Hantraye, Philippe ^e,f   Brouillet, Emmanuel ^e,f   Buée, Luc ^a,b,c   Colin, Morvane ^a,b,c  

^a INSERM   (France)

^b JEAN PIERRE AUBERT RESEARCH CENTER   (France)

^c CMRR   (France)

^d LABORATOIRE D ENZYMOLOGIE ET BIOCHIMIE STRUCTURALES   (France)

^e INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^f Molecular Imaging Research Center   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL ACTIVITY; CELL COMMUNICATION; CONTROLLED STUDY; CYTOPLASM VESICLE; DISEASE ASSOCIATION; ECTOSOME; EMBRYO; EXOSOME; INTERSTITIAL FLUID; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; PROTEIN AGGREGATION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; PROTEIN TRANSPORT; RAT; SECRETORY PATHWAY; TAUOPATHY; ANIMAL; ANIMAL EMBRYO; CELL CULTURE; CYTOLOGY; ELECTRON MICROSCOPY; EXTRACELLULAR FLUID; HUMAN; MEMBRANE MICROPARTICLE; METABOLISM; WISTAR RAT;

ANIMALS; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; EMBRYO, MAMMALIAN; EXOSOMES; EXTRACELLULAR FLUID; HUMANS; MICROSCOPY, ELECTRON; NEURONS; RATS; RATS, WISTAR; TAU PROTEINS;

EID: 84903535019     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100760     Document Type: Article

References (69)

1. Buee L, Bussiere T, Buee-Scherrer V, Delacourte A, Hof PR (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Brain Res Rev 33: 95-130.
2. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259.
3. Delacourte A, David JP, Sergeant N, Buee L, Wattez A, et al. (1999) The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52: 1158-1165. (Pubitemid 29177915)
4. Verny M, Duyckaerts C, Agid Y, Hauw JJ (1996) The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases. Brain 119 (Pt 4): 1123-1136. (Pubitemid 26300715)
5. Saito Y, Ruberu NN, Sawabe M, Arai T, Tanaka N, et al. (2004) Staging of argyrophilic grains: an age-associated tauopathy. J Neuropathol Exp Neurol 63: 911-918. (Pubitemid 39202494)
6. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, et al. (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 11: 909-913.
7. de Calignon A, Polydoro M, Suarez-Calvet M, William C, Adamowicz DH, et al. (2012) Propagation of tau pathology in a model of early Alzheimer's disease. Neuron 73: 685-697.
8. Liu L, Drouet V, Wu JW, Witter MP, Small SA, et al. (2012) Trans-synaptic spread of tau pathology in vivo. PLoS One 7: e31302.
9. Sultan A, Nesslany F, Violet M, Begard S, Loyens A, et al. (2011) Nuclear tau, a key player in neuronal DNA protection. J Biol Chem 286: 4566-4575.
10. Brandt R, Leger J, Lee G (1995) Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J Cell Biol 131: 1327-1340.
11. Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, et al. (2010) Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 142: 387-397.
12. Pooler AM, Phillips EC, Lau DH, Noble W, Hanger DP (2013) Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep 14: 389-394.
13. Chai X, Dage JL, Citron M (2012) Constitutive secretion of tau protein by an unconventional mechanism. Neurobiol Dis 48: 356-366.
14. Karch CM, Jeng AT, Goate AM (2012) Extracellular tau levels are influenced by variability in tau that is associated with tauopathies. J Biol Chem 287: 42751-42762.
15. Kim W, Lee S, Hall GF (2010) Secretion of human tau fragments resembling CSF-tau in Alzheimer's disease is modulated by the presence of the exon 2 insert. FEBS Lett 584: 3085-3088.
16. Simon D, Garcia-Garcia E, Royo F, Falcon-Perez JM, Avila J (2012) Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles. FEBS Lett 586: 47-54.
17. Santa-Maria I, Varghese M, Ksiezak-Reding H, Dzhun A, Wang J, et al. (2012) Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of tau protein in aggresomes. J Biol Chem 287: 20522-20533.
18. Saman S, Kim W, Raya M, Visnick Y, Miro S, et al. (2012) Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem 287: 3842-3849.
19. Kfoury N, Holmes BB, Jiang H, Holtzman DM, Diamond MI (2012) Transcellular Propagation of Tau Aggregation by Fibrillar Species. J Biol Chem 287: 19440-19451.
20. Frost B, Jacks RL, Diamond MI (2009) Propagation of tau misfolding from the outside to the inside of a cell. J Biol Chem 284: 12845-12852.
21. Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, et al. (2012) Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 10: e1001450.
22. Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteomics 73: 1907-1920.
23. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, et al. (1996) B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183: 1161-1172. (Pubitemid 26113979)
24. Thery C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9: 581-593.
25. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles: artefacts no more. Trends Cell Biol 19: 43-51.
26. Davizon P, Munday AD, Lopez JA (2010) Tissue factor, lipid rafts, and microparticles. Semin Thromb Hemost 36: 857-864.
27. Piccin A, Murphy WG, Smith OP (2007) Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21: 157-171. (Pubitemid 46529055)
28. Kempf M, Clement A, Faissner A, Lee G, Brandt R (1996) Tau binds to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner. J Neurosci 16: 5583-5592. (Pubitemid 26293382)
29. Shea TB, Spencer MJ, Beermann ML, Cressman CM, Nixon RA (1996) Calcium influx into human neuroblastoma cells induces ALZ-50 immunoreactivity: involvement of calpain-mediated hydrolysis of protein kinase C. J Neurochem66: 1539-1549. (Pubitemid 26090557)
30. Lee S, Kim W, Li Z, Hall GF (2012) Accumulation of vesicle-associated human tau in distal dendrites drives degeneration and tau secretion in an in situ cellular tauopathy model. Int J Alzheimers Dis 2012: 172837.
31. Usardi A, Pooler AM, Seereeram A, Reynolds CH, Derkinderen P, et al. (2011) Tyrosine phosphorylation of tau regulates its interactions with Fyn SH2 domains, but not SH3 domains, altering the cellular localization of tau. FEBS J 278: 2927-2937.
32. Doeuvre L, Plawinski L, Toti F, Angles-Cano E (2009) Cell-derived microparticles: a new challenge in neuroscience. J Neurochem 110: 457-468.
33. Baron M, Boulanger CM, Staels B, Tailleux A (2012) Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? J Cell Mol Med 16: 1365-1376.
34. Sergeant N, Sablonniere B, Schraen-Maschke S, Ghestem A, Maurage CA, et al. (2001) Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet 10: 2143-2155. (Pubitemid 32998826)
35. Sautiere PE, Caillet-Boudin ML, Wattez A, Delacourte A (1994) Detection of Alzheimer-type tau proteins in okadaic acid-treated SKNSH-SY5Y neuroblastoma cells. Neurodegeneration 3: 53-60.
36. Caillierez R, Begard S, Lecolle K, Deramecourt V, Zommer N, et al. (2013) Lentiviral Delivery of the Human Wild-type Tau Protein Mediates a Slow and Progressive Neurodegenerative Tau Pathology in the Rat Brain. Mol Ther 21: 1358-1368.
37. Galas MC, Dourlen P, Begard S, Ando K, Blum D, et al. (2006) The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease. J Biol Chem 281: 19296-19304. (Pubitemid 44035434)
38. Lecolle K, Begard S, Caillierez R, Demeyer D, Grellier E, et al. (2013) Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells using fiber-modified adenoviral vectors. Gene Ther 20: 283-297.
39. Schraen-Maschke S, Sergeant N, Dhaenens CM, Bombois S, Deramecourt V, et al. (2008) Tau as a biomarker of neurodegenerative diseases. Biomark Med 2: 363-384.
40. Troquier L, Caillierez R, Burnouf S, Fernandez-Gomez FJ, Grosjean ME, et al. (2012) Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach. Curr Alzheimer Res 9: 397-405.
41. Dujardin S, Lécolle K, Caillierez R, Bégard S, Zommer N, et al. (2014) Neuron-to-neuron wild-type Tau protein transfer through a trans-synaptic mechanism: Relevance to sporadic Tauopathies. Acta Neuropathologica Communications In press.
42. Thery C, Boussac M, Veron P, Ricciardi-Castagnoli P, Raposo G, et al. (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166: 7309-7318. (Pubitemid 32525606)
43. de Gassart A, Geminard C, Fevrier B, Raposo G, Vidal M (2003) Lipid raftassociated protein sorting in exosomes. Blood 102: 4336-4344. (Pubitemid 37494093)
44. Cuervo AM, Wong ES, Martinez-Vicente M (2010) Protein degradation, aggregation, and misfolding. Mov Disord 25 Suppl 1: S49-54.
45. Raposo G, Stoorvogel W (2013) Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 200: 373-383.
46. Wang Y, Martinez-Vicente M, Kruger U, Kaushik S, Wong E, et al. (2010) Synergy and antagonism of macroautophagy and chaperone-mediated autophagy in a cell model of pathological tau aggregation. Autophagy 6: 182-183.
47. Yamada K, Cirrito JR, Stewart FR, Jiang H, Finn MB, et al. (2011) In vivo microdialysis reveals age-dependent decrease of brain interstitial fluid tau levels in P301S human tau transgenic mice. J Neurosci 31: 13110-13117.
48. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, et al. (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci U S A 100: 10032-10037. (Pubitemid 37087063)
49. Wang YP, Biernat J, Pickhardt M, Mandelkow E, Mandelkow EM (2007) Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc Natl Acad Sci U S A 104: 10252-10257. (Pubitemid 47175295)
50. Borroni B, Gardoni F, Parnetti L, Magno L, Malinverno M, et al. (2009) Pattern of Tau forms in CSF is altered in progressive supranuclear palsy. Neurobiol Aging 30: 34-40.
51. Horowitz PM, Patterson KR, Guillozet-Bongaarts AL, Reynolds MR, Carroll CA, et al. (2004) Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease. J Neurosci 24: 7895-7902. (Pubitemid 39215694)
52. Plouffe V, Mohamed NV, Rivest-McGraw J, Bertrand J, Lauzon M, et al. (2012) Hyperphosphorylation and cleavage at D421 enhance tau secretion. PLoS One 7: e36873.
53. Hanisch K, Soininen H, Alafuzoff I, Hoffmann R (2010) Analysis of human tau in cerebrospinal fluid. J Proteome Res 9: 1476-1482.
54. Andrei C, Dazzi C, Lotti L, Torrisi MR, Chimini G, et al. (1999) The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol Biol Cell 10: 1463-1475. (Pubitemid 29230902)
55. de Calignon A, Fox LM, Pitstick R, Carlson GA, Bacskai BJ, et al. (2010) Caspase activation precedes and leads to tangles. Nature 464: 1201-1204.
56. Ramcharitar J, Albrecht S, Afonso VM, Kaushal V, Bennett DA, et al. (2013) Cerebrospinal fluid tau cleaved by caspase-6 reflects brain levels and cognition in aging and Alzheimer disease. J Neuropathol Exp Neurol 72: 824-832.
57. Ekinci FJ, Shea TB (2000) Phosphorylation of tau alters its association with the plasma membrane. Cell Mol Neurobiol 20: 497-508. (Pubitemid 30439511)
58. Maas T, Eidenmuller J, Brandt R (2000) Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J Biol Chem 275: 15733-15740. (Pubitemid 30366871)
59. Diaz-Hernandez M, Gomez-Ramos A, Rubio A, Gomez-Villafuertes R, Naranjo JR, et al. (2010) Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau. J Biol Chem 285: 32539-32548.
60. Pooler AM, Usardi A, Evans CJ, Philpott KL, Noble W, et al. (2012) Dynamic association of tau with neuronal membranes is regulated by phosphorylation. Neurobiol Aging33: 431 e427-438.
61. Gomez-Ramos A, Diaz-Hernandez M, Cuadros R, Hernandez F, Avila J (2006) Extracellular tau is toxic to neuronal cells. FEBS Lett 580: 4842-4850. (Pubitemid 44286844)
62. Kaufman SK, Diamond MI (2013) Prion-like propagation of protein aggregation and related therapeutic strategies. Neurotherapeutics 10: 371-382.
63. Gerson JE, Kayed R (2013) Formation and propagation of tau oligomeric seeds. Front Neurol 4: 93.
64. Castillo-Carranza DL, Sengupta U, Guerrero-Munoz MJ, Lasagna-Reeves CA, Gerson JE, et al. (2014) Passive Immunization with Tau Oligomer Monoclonal Antibody Reverses Tauopathy Phenotypes without Affecting Hyperphosphorylated Neurofibrillary Tangles. J Neurosci 34: 4260-4272.
65. Kim W, Lee S, Jung C, Ahmed A, Lee G, et al. (2010) Interneuronal transfer of human tau between Lamprey central neurons in situ. J Alzheimers Dis 19: 647- 664.
66. Liu C, Gotz J (2013) Profiling murine tau with 0N, 1N and 2N isoform-specific antibodies in brain and peripheral organs reveals distinct subcellular localization, with the 1N isoform being enriched in the nucleus. PLoS One 8: e84849.
67. EL Andaloussi S, Mager I, Breakefield XO, Wood MJ (2013) Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12: 347-357.
68. Choi DS, Lee J, Go G, Kim YK, Gho YS (2013) Circulating extracellular vesicles in cancer diagnosis and monitoring: an appraisal of clinical potential. Mol Diagn Ther 17: 265-271.
69. Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 121: 171-181.